Barclays

Barclays’s Phathom Pharmaceuticals PHAT Stock Holding History

Barclays’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$282K	Sell	25,357 -59,502	-70%	-$752K	﹤0.01%	3506
2025 Q4	$1.41M	Sell	84,859 -43,497	-34%	-$621K	﹤0.01%	3191
2025 Q3	$1.51M	Buy	128,356 +46,186	+56%	+$477K	﹤0.01%	3094
2025 Q2	$788K	Buy	82,170 +27,268	+50%	+$151K	﹤0.01%	3495
2025 Q1	$344K	Sell	54,902 -21,561	-28%	-$131K	﹤0.01%	3746
2024 Q4	$621K	Buy	76,463 +18,656	+32%	+$231K	﹤0.01%	3691
2024 Q3	$1.05M	Buy	57,807 +45,402	+366%	+$635K	﹤0.01%	3326
2024 Q2	$128K	Sell	12,405 -15,794	-56%	-$163K	﹤0.01%	3791
2024 Q1	$299K	Sell	28,199 -21,473	-43%	-$182K	﹤0.01%	3900
2023 Q4	$454K	Buy	49,672 +36,437	+275%	+$314K	﹤0.01%	3941
2023 Q3	$137K	Buy	13,235 +2,422	+22%	+$33.2K	﹤0.01%	3467
2023 Q2	$155K	Sell	10,813 -1,713	-14%	-$19.8K	﹤0.01%	3371
2023 Q1	$89.4K	Buy	12,526 +3,647	+41%	+$32K	﹤0.01%	4239
2022 Q4	$99.6K	Buy	8,879 +7,903	+810%	+$81.5K	﹤0.01%	4224
2022 Q3	$11K	Sell	976 -3,791	-80%	-$36.1K	﹤0.01%	4268
2022 Q2	$40K	Sell	4,767 -2,200	-32%	-$22.6K	﹤0.01%	4126
2022 Q1	$94K	Buy	+6,967	New	+$113K	﹤0.01%	3813

Other funds holding PHAT

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Ensign Peak Advisors

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return